BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8067762)

  • 1. Rifampin for therapy of experimental pneumococcal meningitis in rabbits.
    Nau R; Kaye K; Sachdeva M; Sande ER; Täuber MG
    Antimicrob Agents Chemother; 1994 May; 38(5):1186-9. PubMed ID: 8067762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
    Kim YS; Liu Q; Chow LL; Täuber MG
    Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.
    Nau R; Schmidt T; Kaye K; Froula JL; Täuber MG
    Antimicrob Agents Chemother; 1995 Mar; 39(3):593-7. PubMed ID: 7793857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
    Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
    J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Uscher MI; Shelton S; Olsen KD; McCracken GH
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1320-4. PubMed ID: 8092832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.
    Klugman KP; Friedland IR; Bradley JS
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1988-92. PubMed ID: 8540704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis.
    Force E; Taberner F; Cabellos C; Ribes S; Doménech A; Tubau F; Viladrich PF; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):807-11. PubMed ID: 19221815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis.
    Domenech A; Cabellos C; Ribes S; Tubau F; Viladrich PF; Liñares J; Gudiol F
    Microb Drug Resist; 2003; 9 Suppl 1():S53-9. PubMed ID: 14633368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.
    Grandgirard D; Burri M; Agyeman P; Leib SL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4289-95. PubMed ID: 22644021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemifloxacin is effective in experimental pneumococcal meningitis.
    Smirnov A; Wellmer A; Gerber J; Maier K; Henne S; Nau R
    Antimicrob Agents Chemother; 2000 Mar; 44(3):767-70. PubMed ID: 10681354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.